Abstract
MAB-T88 is a human monoclonal IgM antibody directed at the lipopolysaccharide of gram-negative bacteria. A protocol was designed to identify a group of septic patients with a very high likelihood of gram-negative bacteremia. All 6 patients entered in the protocol had a gram-negative source, and 4 of 6 had gram-negative bacteremia. In this patient population, MAB-T88 was shown to be safe with an effective half-life of 19.1 hours.
Original language | English (US) |
---|---|
Pages (from-to) | 36-39 |
Number of pages | 4 |
Journal | Human Antibodies and Hybridomas |
Volume | 4 |
Issue number | 1 |
State | Published - 1993 |
Externally published | Yes |
ASJC Scopus subject areas
- Immunology